Frederick Matthew Lang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathies | 2 | 2024 | 2058 | 0.770 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2019 | 11 | 0.690 |
Why?
|
| Bioprosthesis | 1 | 2023 | 593 | 0.620 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 892 | 0.540 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 1464 | 0.470 |
Why?
|
| Rare Diseases | 1 | 2019 | 630 | 0.450 |
Why?
|
| Recovery of Function | 1 | 2024 | 2978 | 0.450 |
Why?
|
| Exosomes | 1 | 2018 | 417 | 0.430 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2023 | 1564 | 0.410 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 504 | 0.410 |
Why?
|
| Heart Transplantation | 1 | 2024 | 3306 | 0.360 |
Why?
|
| Aortic Valve Stenosis | 1 | 2023 | 2023 | 0.360 |
Why?
|
| Kidney Transplantation | 1 | 2024 | 4278 | 0.320 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 15425 | 0.290 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1664 | 0.280 |
Why?
|
| Heart Failure | 3 | 2024 | 11879 | 0.250 |
Why?
|
| Glioma | 1 | 2018 | 3498 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3110 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3232 | 0.200 |
Why?
|
| MicroRNAs | 1 | 2018 | 3789 | 0.190 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2024 | 180 | 0.180 |
Why?
|
| Treatment Outcome | 5 | 2024 | 65286 | 0.180 |
Why?
|
| PubMed | 1 | 2019 | 129 | 0.160 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2019 | 80 | 0.160 |
Why?
|
| beta-Galactosidase | 1 | 2019 | 573 | 0.160 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 643 | 0.150 |
Why?
|
| Amyloidosis | 1 | 2024 | 877 | 0.130 |
Why?
|
| Prosthesis Design | 1 | 2023 | 2120 | 0.130 |
Why?
|
| Gene Fusion | 1 | 2018 | 356 | 0.120 |
Why?
|
| Aortic Valve | 1 | 2023 | 1966 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2024 | 1287 | 0.100 |
Why?
|
| Patient Selection | 1 | 2024 | 4252 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2018 | 3618 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2024 | 81657 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1756 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 6105 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2662 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3605 | 0.080 |
Why?
|
| Humans | 11 | 2024 | 766812 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 59548 | 0.080 |
Why?
|
| Registries | 1 | 2024 | 8352 | 0.070 |
Why?
|
| Aged | 3 | 2024 | 171344 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 8045 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 39312 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10451 | 0.050 |
Why?
|
| Apoptosis | 1 | 2018 | 9514 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8734 | 0.040 |
Why?
|
| Male | 3 | 2024 | 364154 | 0.040 |
Why?
|
| Middle Aged | 2 | 2024 | 223267 | 0.040 |
Why?
|
| Infant | 1 | 2019 | 36459 | 0.040 |
Why?
|
| Female | 2 | 2024 | 396532 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2018 | 1409 | 0.020 |
Why?
|
| Echocardiography | 1 | 2024 | 5038 | 0.020 |
Why?
|
| Mice | 1 | 2018 | 81898 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2018 | 1608 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 2045 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 22350 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2022 | 12430 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 168939 | 0.020 |
Why?
|
| Inflammation | 1 | 2022 | 10863 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2024 | 24299 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8623 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20146 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 16044 | 0.010 |
Why?
|